At Natreon, Inc., we focus our efforts on developing novel compounds extracted from the traditional botanicals of Ayurvedic medicine. With state-of-the-art research facilities in India and a team of several Ph.D.s, headed by Dr. Shibnath Ghosal,  whose breakthrough discoveries were first published more than 40 years ago, we have created a broad portfolio of products and technologies. All of our products are supported by rigorous scientific work, clinical studies, publications and intellectual property.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Under the dynamic leadership and foresightedness of Mr. Rahul Mithal , AMPUS LIFE SCINCES LIMITED. was incepted/ incorporated in 2002. With its marketing office at NAVI MUMBAI,AMPUS LIFE SCINCES LIMITE started its ethical operations, and within few years of launch, company expanded its specialty range with more than 40 latest products and widened its horizons to mark its presence in the Indian Pharmaceutical field.

Famy care is a global player in the Female Health Care Segment with a focus on Hormonal & Reproductive Health Care Products. Famy care believes in the right of women to be informed about their reproductive healthcare choices and to make good health accessible to all. In a very short span of time we have become the largest manufacturer of Hormonal Tablets.

The Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously.

About Authors:
Dr. Amit Gangwal,
Smriti College of Pharmaceutical Education,
Indore

Abstract
For running any business or organization their products or services should be of utmost quality keeping other things aside. These products or services are known in commerce by their names. These names are called brand names and these are assigned by the owner or innovator or researcher or sponsor of that product or service depending on the type of produce and various parameters. Though company introduces the brand in commerce but after its (brand’s) establishment, brand becomes the identity of company. Brand names are most important attribute of a product after its quality and packing from end user’s (customer) point of view. Successful brand names never escape from the memory of consumer. Few such brand names are Bislery, Maggi, Vicks, Surf Excel, Coca-Cola, Google etc. Few reputed and well known pharmaceutical brands are Corex, Lipitor, Gleevac, Viagra etc. In present article various process to name a drug and a pharmaceutical formulations’ name (brand name) have been described. Article throws light on generic, chemical and brand names of a drug or formulations besides few case studies and guidelines.

Under the dynamic leadership and foresightedness of Mr. Rakesh Dutt , Ion Healthcare Pvt. Ltd. was incepted/ incorporated in 1999. With its marketing office at Ludhiana, Ion Healthcare Pvt. Ltd. started its nationwide ethical operations, and within few years of launch, company expanded its specialty range with more than 50 latest products and widened its horizons to mark its presence in the Indian Pharmaceutical field.

Franco-Indian Pharmaceuticals Pvt. Ltd., a name that stands for quality and innovation, is one of the major players in the Pharmaceutical Industry in India.
Our innovative, value added products improve the quality of life of people and ease their sufferings and help them to enjoy, longer, healthier and more productive lives.

Established in 1920, Bridge and Roof has since come under the adminstrative control of the Department of Heavy Industry, Ministry of Heavy Industries and Public Enterprises, Government of India. From a tiny acorn, today B&R has grown into a giant oak with an annual turnover of IRs. 1333 Crores, serving both Private and Public Sectors, Indian and Overseas.

The Housing Development Finance Corporation Limited (HDFC) was amongst the first to receive an 'in principle' approval from the Reserve Bank of India (RBI) to set up a bank in the private sector, as part of the RBI's liberalisation of the Indian Banking Industry in 1994. The bank was incorporated in August 1994 in the name of 'HDFC Bank Limited', with its registered office in Mumbai, India. HDFC Bank commenced operations as a Scheduled Commercial Bank in January 1995.

Ahlcon Parenterals India Ltd. was established in year 1992 with a motto to provide BFS technology - Large Volume Parenterals / Small Volume Parenterals for the consumers at affordable prices.The driving force was the need of leading pharma companies for reliable and assured quality manufacturer in this field.

ABOUT AUTHORS:
G. JYOTHI REDDY*¹, A. SRILAKSHMI¹, S.SINDHUJA², N.K. SREE¹, SK.AFSAR¹, B.PRIYANKA¹, R.E.AMRUTHA^1
1 Department of Pharmacology, P. Rami Reddy Memorial College of Pharmacy, Kadapa, Andhra Pradesh, India.
² Sri Padmavathi School Of Pharmacy, Tiruchanoor, Tirupathi, Andhra Pradesh, India

ABSTRACT
The ethanolic leaf extract of Allophylus serratus shown significant (p<0.05) antidiarrheal activity on gastrointestinal motility with  castor oil- induced diarrheal model in rats. The results obtained revealed that the leaf extract possess pharmacological activity against diarrhoea and may possibly explain the use of the plant in traditional medicine. The extract tested at 200 and 400 mg/kg like the standard drug, loperamide significantly inhibited the frequency of defecation droppings compared to untreated control rats. This result is in support of previous claims in respect of antidiarrhoeal herbs.

About Authors:
Dr. BJ Mahendra kumar^*1, Jagadish babu D², Jyothi K²,
^*1Professor, Department of Clinical pharmacy,
Sri Adichunchanagiri College of pharmacy, Mandya, Karnataka, India.
²Scholars, Department of Clinical pharmacy,
Sri Adichunchanagiri College of pharmacy, Karnataka,
Mandya, India.

Introduction:
Antibiotics are among the most widely prescribed therapeutic agents among paediatrics patients.¹ As we all know, the advantage of therapy with a cephalosporin not only lies in its rather broad spectrum but also in its low toxicity and the drug can be used safely in pregnant women and children. Such therapy can reduce the duration of hospitalization if the susceptible bacterial pathogens have been almost eradicated by a parental cephalosporin and patient’s condition has been brought under control.² Despite their widespread use in paediatrics, few antibiotics have been studied adequately to be considered safe and effective for use in children. Oral third-generation cephalosporins used commonly in paediatrics include cefixime, cefpodoxime, ceftibuten, and cefdinir.³

Parenteral Drugs (India) Limited is one of the leading and fastest growing healthcare company, that has constantly followed a path created by its own will, hard work and determination. PDPL is involved in research, production and manufacturing of pharmaceutical products viz. intravenous infusion, tablets, capsules, liquids syrups, injections etc.